Literature DB >> 18316790

Determinants of RASistance to anti-epidermal growth factor receptor agents.

José Baselga, Neal Rosen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18316790     DOI: 10.1200/JCO.2007.15.3700

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  24 in total

1.  Identification of predictive markers of response to the MEK1/2 inhibitor selumetinib (AZD6244) in K-ras-mutated colorectal cancer.

Authors:  John J Tentler; Sujatha Nallapareddy; Aik Choon Tan; Anna Spreafico; Todd M Pitts; M Pia Morelli; Heather M Selby; Maria I Kachaeva; Sara A Flanigan; Gillian N Kulikowski; Stephen Leong; John J Arcaroli; Wells A Messersmith; S Gail Eckhardt
Journal:  Mol Cancer Ther       Date:  2010-10-05       Impact factor: 6.261

Review 2.  Inhibitors of phosphatidylinositol-3-kinase in cancer therapy.

Authors:  Nathan T Ihle; Garth Powis
Journal:  Mol Aspects Med       Date:  2010-02-20

Review 3.  Anti-EGFR and anti-VEGF agents: important targeted therapies of colorectal liver metastases.

Authors:  Qing-Yang Feng; Ye Wei; Jing-Wen Chen; Wen-Ju Chang; Le-Chi Ye; De-Xiang Zhu; Jian-Min Xu
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 4.  Genomic era diagnosis and management of hereditary and sporadic colon cancer.

Authors:  Edward David Esplin; Michael Paul Snyder
Journal:  World J Clin Oncol       Date:  2014-12-10

Review 5.  Advances in the treatment of metastatic colorectal cancer.

Authors:  Carla Kurkjian; Shivaani Kummar
Journal:  Am J Ther       Date:  2009 Sep-Oct       Impact factor: 2.688

6.  A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes.

Authors:  Debora Fumagalli; Patrick G Gavin; Yusuke Taniyama; Seung-Il Kim; Hyun-Joo Choi; Soonmyung Paik; Katherine L Pogue-Geile
Journal:  BMC Cancer       Date:  2010-03-16       Impact factor: 4.430

7.  Oncogenic KRAS modulates mitochondrial metabolism in human colon cancer cells by inducing HIF-1α and HIF-2α target genes.

Authors:  Sang Y Chun; Craig Johnson; Joseph G Washburn; Marcia R Cruz-Correa; Duyen T Dang; Long H Dang
Journal:  Mol Cancer       Date:  2010-11-13       Impact factor: 27.401

Review 8.  Clinical biomarkers in oncology: focus on colorectal cancer.

Authors:  Wendy De Roock; Bart Biesmans; Jef De Schutter; Sabine Tejpar
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

9.  Target-specific randomized discontinuation trial design: a novel approach in molecular therapeutics.

Authors:  Matthew D Galsky; Tal Zaks; Habib Hassani; Linda Vocila; Guru Sonpavde; Thomas E Hutson; Daniel D Von Hoff
Journal:  Invest New Drugs       Date:  2009-03-06       Impact factor: 3.850

Review 10.  EGF-receptor regulation of matrix metalloproteinases in epithelial ovarian carcinoma.

Authors:  Laurie G Hudson; Natalie M Moss; M Sharon Stack
Journal:  Future Oncol       Date:  2009-04       Impact factor: 3.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.